Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Arthritis Research & Therapy

Figure 5

From: Therapeutic effects of antibodies to tumor necrosis factor-α, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis

Figure 5

Effective treatments tend to alter anti-GPI antibody production. Glucose-6-phosphate isomerase (GPI)-induced arthritic mice were treated with 100 μg anti-tumor necrosis factor (TNF)-α mAb, anti-IL-6 mAb, cytotoxic T-lymphocyte antigen 4 immunoglobulin (CTLA-4Ig), and anti-IL-12 mAb on day 8, and CTLA-4 Ig on day 12. Serum samples were collected on day 14. The titers of anti-GPI antibodies were analyzed by enzyme-linked immunosorbent assay. Each symbol represents a single animal. Data are expressed as mean ± standard deviation of optical density.

Back to article page